Showing results (1451-1460 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|October 1, 2013
Nutrition and physical activity influence on breast cancer incidence and outcomeRowan T ChlebowskiBreast (Edinburgh, Scotland)|October 1, 2013
The metastatic microenvironment of breast cancer: clinical implicationsR E Coleman, W Gregory, H Marshall, et al.Breast (Edinburgh, Scotland)|October 1, 2013
Extracellular matrix components in breast cancer progression and metastasisThordur OskarssonBreast (Edinburgh, Scotland)|October 1, 2013
Characterization and clinical impact of residual disease after neoadjuvant chemotherapyGiuseppe VialeBreast (Edinburgh, Scotland)|October 1, 2013
Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibriumGiuseppe Curigliano, Carmen Criscitiello, Angela Esposito, et al.Breast (Edinburgh, Scotland)|October 2, 2013
Therapeutic strategies in male breast cancer: clinical implications of chromosome 17 gene alterations and molecular subtypesHans-Ulrich Schildhaus, Lars Schroeder, Sabine Merkelbach-Bruse, et al.Breast (Edinburgh, Scotland)|October 2, 2013
Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapyZhaoqing Fan, Jinfeng Li, Tianfeng Wang, et al.Breast (Edinburgh, Scotland)|August 20, 2013
Multiple Step-section Frozen Section sentinel lymph node biopsy--a review of 717 patientsJeffrey Lim, Sasirekha Govindarajulu, Ajay Sahu, et al.Breast (Edinburgh, Scotland)|August 20, 2013
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: a multicentric Turkish Oncology Group (TOG) trialP Saip, Y Eralp, F Sen, et al.Breast (Edinburgh, Scotland)|August 5, 2015
Clinical utility of genetic signatures in selecting adjuvant treatment: Risk stratification for early vs. late recurrencesDaniel F HayesPageof 366